CA2216256A1 - Substance delivery device - Google Patents

Substance delivery device Download PDF

Info

Publication number
CA2216256A1
CA2216256A1 CA002216256A CA2216256A CA2216256A1 CA 2216256 A1 CA2216256 A1 CA 2216256A1 CA 002216256 A CA002216256 A CA 002216256A CA 2216256 A CA2216256 A CA 2216256A CA 2216256 A1 CA2216256 A1 CA 2216256A1
Authority
CA
Canada
Prior art keywords
substance
delivery device
conduit
animal
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002216256A
Other languages
French (fr)
Inventor
Hugh Philip Jellie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Animal Technology Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2216256A1 publication Critical patent/CA2216256A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D17/00Devices for indicating trouble during labour of animals ; Methods or instruments for detecting pregnancy-related states of animals
    • A61D17/002Devices for indicating trouble during labour of animals ; Methods or instruments for detecting pregnancy-related states of animals for detecting period of heat of animals, i.e. for detecting oestrus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069Devices for implanting pellets, e.g. markers or solid medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers

Abstract

According to one aspect of the present invention there is provided a substance delivery device (1) capable of insertion into a body cavity of an animal, including delivery apparatus (11) capable of actively being controlled to deliver a substance to an outlet, and retention apparatus (2, 3) capable of retaining the substance delivery device within the body cavity of an animal. In one embodiment, a microprocessor (18) can be remotely programmed to enable control over the delivery device after it is placed in the animal. The microprocessor (18) can also communicate with an external device to enable the operation of the delivery device to be determined. The invention may also include sensors to monitor the environment around the delivery device, to determine when a substance should be delivered into the body.

Description

CA 022162~6 1997-09-23 SUBSTANCE DELIVERY DEVICE
TECHNICAL FIELD
This invention relates to a substance delivery device which incorporates a controlled delivery a~dlus and retention apparatus for said substance delivery device.
Reference throughout this specification shall be made to the substance delivery device as being for the introduction of substances within a body cavity, for example such as intravaginal, intraruminal devices and the like for domestic ~nim~l~, such as cows. It should be appreciated however, that the principles of the present invention can apply to far wider applications than this and can be used with respect to delivery devices where 10 some control is required.
In particular, it is envisaged that the retention a~paldllls will enable the substance delivery device to be most commonly used in situations where said device, capable of insertion into a passage or body cavity of an animal, is required to be retained in said passage or body cavity. Such passages or body cavities are generally associated with the 15 reproductive or digestive systems of an animal, and include the vagina, uterus, stomach, rumen, and so forth. Such devices are inserted into an animal's body cavity where control of parasites, nutrition, reproduction, growth, and so forth are desired, and where this control is effected through çh~omic~l and/or hormonal intervention.
However, the present invention could have applications outside this field. Accordingly, these delivery devices may not necessarily be within the body of zlnim~l~ or hllm~n~, but may interact with other environments such as horticultural, industrial, domestic and so forth.
BACKGROUND ART
Commonly, substance delivery devices inserted into a living animal for dispensing substances to the animal also employ retention apparatus. Accordingly, a range of retention apparata exist for retaining the substance delivery device within a passage or body cavity of an animal.
Some systems commonly used for retaining delivery devices capable of being inserted into a body cavity of an animal, incorporate a compressible helical coil, such as in Patent Nos. 228382 and 190350. The compressible coil is frequently capable of returning to the required shape after the device has been inserted into the animal's body cavity.

SI~BSTITUTE SHEET

CA 022162~6 1997-09-23 W O 96/29025 PCTANZ96tO0024 However, such coils rely on the overall bulk of the coil to retain the coil within the body cavity of an animal. Accordingly, the blllkin~ss of the coil may impede the flow of body secretions which may not be desirable. An unimpeded flow of body secretions is necessary for the normal biological functioning of the animal. Such body secretions S include mucus, where such a device is used intravaginally.
In addition, the coil is typically capable of e~p~n~ling and pressing against a considerable area of the wall of a body cavity of an animal, to the extent that it may be too bulky to pass back through passages leading into or out of the body cavity. Accordingly, when the functional utility of the device has been exhausted, removal of the device may be 10 difficult.
Other systems commonly employed for retaining devices within the body cavity of an animal have incorporated a number of lobes, similar to those of Patent No. 193976 and Patent No. 200564. These lobes are often flexible enough to fold over onto each other for insertion into a body cavity of an animal and then spring open after the device is inside 15 the animal. Frequently, the lobes pelro.lll a dual purpose of ret~ining the device within an animal's body cavity and of releasing an active ingredient, often impregnated into the lobe or in the coating around the lobe, into the animal's body cavity. Accordingly, the lobes may have a substantial, even rippled, surface area to ensure that sufficient active ingredient is available to perform the required function. In addition, the lobes are often specifically designed to provide a large surface area to enable the animal's body fluids to act on those surfaces to leach out active ingredients contained within the lobes.
However, the surface area of these devices is again capable of impeding the flow of body secretions. In addition, the natural elasticity of the lobes enables the lobes to be folded over onto each other to enable the device to be inserted into and removed from the animal's body cavity. However, an o~eldlol may be required to manually hold the lobes in the folded orientation, during insertion of the device into the animal' s body cavity.
Further systems incorporate hinged legs or branched members, as in Patent Nos. 215635 and 230023, which may extend from one or both ends of ehe body of a device inserted into the body cavity of an animal. Again, these legs or members, as well as the body of the device, are typically impregnated with active ingredients required to be dispensed into the animal. Accordingly, it is desirable that the legs or members add to the overall surface area of the device to enable the active ingredients to be more efficiently leached from the device and into the animal. Again, the common problem associated with such devices and retention systems for these devices, is that initially the increased surface area may impede the flow of the animal's internal body secretions. Particularly, the flow of mucu.s in the vagina of the animal.

SUBSTI~UTE SHE~T

CA 022162~6 1997-09-23 W 096/29025 PCT~NZ96/00024 However, with time, erosion of the polymer layers which contain the active ingredients, effectively reduces the surface area, overall size, and overall weight of the device. A
problem is therefore that as the device gets smaller and lighter it does not have the same retentive ability.
5 In addition, such systems typically require an applicator, such as those described in Patent Nos. 215483 and 207341. These applicators hold the legs or members into arequired position to enable the device and the retention a~pal~Ltus to be inserted into the animal' s body cavity.
Often the applicators are complex or bulky structures, and are separate from the devices 10 which they are capable of inserting. Inclusion of an applicator with the device may increase the costs of m~nllf~cture, and require insertion of the device into the applicator thereby e~ten~ling the time associated with inserting devices into the ~nim~lc Yet other systems may incorporate a number of distensible ribs, such as in Patent No.
173926. The ribs are capable of being distended into a possible ret~inin~; position by the 15 action of a plunger system. When the plunger system is released the distensible ribs return to the Im~licttonded position for withdrawal. However, these devices are typically used for single applications of ph~rm~reutic~l formulations into the body cavity of an animal and are not int~on~le.rl to, nor are suitable for, ret:~ining device over longer periods.
The bulkiness of the plunger system, if left attached to the device could be a source of 20 discomfort to the animal; the ~lict~nsihle ribs are typically lln.cllitPcl to ret~ining a device in a larger body cavity; and the surface area of the ribs would impede the body's flow of secretions.
Yet other retention devices may be of sufficient dimensions to be retained in the body cavity of an animal by relying on muscle tension around the retention device. Such 25 devices are typically used as intra-vaginal contraceptive devices for ~nim~lc, such as in Patent No. 173808. However, the dimensions of the retention devicè may prevent penile insertion during attempted intermission by the male animal, andtor impede flows of body secretions, particularly vaginal mucus.
Accordingly, it would be desirable if the retention apparatus of a substance delivery 30 device enabled the delivery device to be easily inserted and removed, yet was reliably retained for required periods, and did not impede flow of body secretions or adversely affect normal functioning by its mere physical presence.
Similarly, a range of delivery apparata for delivering substances are well known, and have broad application.

SUBSTiTUT~ SHEET

CA 022162~6 1997-09-23 W 096/2902S PCT~Z96/00024 Many incorporate pumps and are used to dispense common substances such as petrol and air. Some delivery a~a~ are used inside a living animal to dispense useful subst~nces such as chemicals or drugs.
For example, there are a number of delivery a~paldl~ known that introduce substances S such as hormones intravaginally to cows. The purpose of such a~ t~ is to promote with some accuracy the onset of oestrus. This enables the farmer to artificially inseminate the cows at a time when they are most fertile.
For example, New 7P~l~n~l Patent No. 228382 discloses such a delivery apparatus. The device disclosed consists of a helical coil made up of a number of se~;mentc These 10 segments contain useful substances which are either impregnated into or coated onto.
The substance to be ~1minictPred to the animal is gradually released from the segmPntc of the a~aLus over a period of time by the action of body fluids. Accordingly, sucha~pal~lus relies on the natural processes of diffusion, dissolution, or osmosis to dispense the substance.
Various other delivery apparata as described in New 7P~l~ntl Patent Nos. 207341,200564 and 215635 all release drugs into the body cavity passively, as consequence of the action of body fluids.
However, when controlling oestrus in ~nim~lc for example, different hormones or concentrations need to be released into the animal's body at dirrelellt times. To effect 20 this, previous delivery apparata have had a number of layers, perhaps with different thicknesses, cont~ining both passive and active substances. These enter the body by the diffusion, dissolution or osmosis, all these processes being dependent upon the body fluids surrounding the substance delivery device or delivery ~a.~ within the device.
For example, it may be desirable to introduce into the body for a period of ten days a 25 certain hormone, then no hormone for another ten days and then introduce another hormone for another period of time. The delivery device could have layers of thicknecses proportional to the time it is estimated that these layers will take to dissolve into the body system.
Unfortunately, there are problems associated with these devices incorporating such 30 delivery apparata. All of these devices are passive devices dependent upon the body fluids surrounding them for the introduction of the active substances into the body.

SUBS~ITUTE SHEE~

CA 022162~6 1997-09-23 However, the rate of introduction of these substances is dependent upon a number of factors such as the te,llpel~Lu,c~ mucus concentration, salt concentration, kinetic action and so forth of the body fluids. These factors are variable from animal to animal which leads to variable timing and concentration of the substances being introduced into the 5 body.
Further, with the substances being exposed to the body's environment, it is possible for the layers to be chipped and a completely inapl?~o~liate substance introduced into the body at the wrong time. Hence, such systems tend to restrict themselves to delivery of a single active m~te.ri~l or if more than one, the second m~t~ l iS introduced at the start.
10 In addition, once these delivery devices are inserted into an animal, the delivery of substance into the animal cannot be controlled as it is totally dependent upon the environment that it is in.
The ability to control the amount and timing of dispensation of a substance with any degree of accuracy is difficult, as there is a depentl~.nee upon the external e~viio~ ent to 15 provide the conditions necessary for dispensation to occur, with the conditions dt;tt;llllhling the volume and rate of dispensation. Accordingly, delivery appaldLus reliant on osmosis, diffusion, and dissolution all suffer from inaccuracy in dispensing and inherently have little timing precision.
Alternately, conventional pumps are often large and complicated. They contain moving 20 parts, complex valve systems, are usually difficult to operate with any degree of accuracy, and are often not suitable for insertion into an animal's body. Further, conventional pumps often require regular maintenance.
It would therefore be desirable if there could be provided a delivery device which was small and simple, contained no complex parts, was maintenance free, and which could be 25 used in animal's bodies or other such e,lvil.,.llllents.
It would also be desirable if there could be provided a device which included delivery apparatus capable of being accurately operated to deliver substances into an animal in precise concentrations and with precise timing, and where such a apparatus could operate independently of the environment, or the apparatus could release substances into the 30 environment only when the environment was ideal.
In addition, it would be desirable if there could be effected some control over the deliver~
apparatus after the device is placed in the animal, and/or if there was some way of determining what was happening within the animal with respect to the operation of the device and associated delivery apparatus.

~U~ST~Tl~TE SHEE~

CA 022162~6 1997-09-23 W O 96/29025 PCT~NZ96/00024 It is an object of the present invention to address the above problems or at least to provide the public with a useful choice.
Further objects and advantages of the present invention will now be discussed by way of t~x~mple only.
DISCL~SURE OF INVENTION
According to one aspect of the present invention there is provided a substance delivery device capable of insertion into a body cavity of an animal, including delivery apparatus capable of actively being controlled to deliver a substance to an outlet, and retention aLJ~ s capable of retaining the substance delivery device within the body cavity of an 10 animal.
In preferred embodiments of the present invention the body of the substance delivery device is configured to include a chamber capable of receiving delivery apparatus and associated controlling apparatus, and the attachment and/or operational means of the retention ~ lu~.
1~ The body of the substance delivery device may also be so configured to improve the ease with which the ~llhst~nre delivery device is inserted into and withdrawn from the body of an animal. Accordingly, the body of the substance delivery device may be ~ubstzlnti~lly circular in cross-section, be tapered along its length, may include a thread or so forth for pulling the device out of the animal's body, and so forth.
20 In ~lefelled embodiments of the present invention the retention apparatus is attached to the body of the substance delivery device which is capable of being inserted into and required to be retained in a passage or body cavity of an animal.
For ease of reference the substance delivery device capable of insertion into a body cavity or passage of an animal shall now be referred to simply as the device, although it should 25 be appreciated that this terrn is not intl ntled to be seen as limiting.
According to another aspect of the present invention there is provided a method for ret~ining a substance delivery device substantially as described above within a body cavity of an animal into which the substance delivery device is inserted, via use of retention apparatus.
30 In preferred embodiments of the present invention the retention apparatus is attached to the device capable of being inserted into the vagina of an animal. Although, in other embodiments of the present invention the retention apparatus may also be attached lo a device capable of being inserted into other body cavities or passages of an animal.

SUE~STITU~E ~ ET

CA 022162~6 1997-09-23 In pler~llc;d embodiment of the present invention the retention apparatus is an integral part of the body of a device to which the retention apl?a d~us is ~tt~r.hr-.rl Having the retention apparatus as an integral part of a device obviates problems of having to attach the retention apparatus as a separate portion at a later stage of construction. Further, it S enables the same m:lte.ri~l to be used for both the body of the device and the retention a~alatus. Therefore, where the retention a~p~hdLus is moulded as an integral part of the body of a device, the expense and time associated with construction of the retention a~a dlus and device may be reduced.
However, in other emborli " ,~ of the present invention the retention appaldLus may be a 10 separate portion. Having a retention ap~dlus which is a separate portion, enables the retention apparatus to be ~tt~r h.-.cl to a device at a later stage of construction; enables the retention a~paldLu~ to be made of dirrelelll m~tr-.ri~l~ to the body of the device; may enable a particular form of retention apparatus to be used on a number of different devices; or enables one device to be fitted with any one of a range of retention apparatus depending 15 on the body cavity into which the device is to be inserted.
According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the retention apparatus is located at at least one end of the substance delivery device.
In preferred embodiments of the present invention the retention apparatus is located 20 towards at least one end of the device to which the retention apparatus is attached.
Having the retention apparatus attached to at least one end of the device being retained, obviates problems associated with the retention apparatus impeding the flow of body secretions, such as intravaginal mucus, which may occur where there are retention a~dld~ls located at a number of points along the device.
25 However, in some emborlim~-.nt~ of the present invention the retention apparatus may be located at either end, or at any point along the body of the device. This may beparticularly useful in situations where the flow of internal body secretions is not adversely affected by the retention apparatus. In addition, positioning the retention apparatus at other locations may be required where the strength of internal peristaltic waves within an 30 animal's body cavity is such that a number of retention apparatus, or a need for retention apparatus located in particular positions along the body of the device is required to enable the device to be more reliably retained within the animal's body cavity.
., SUBSTITUTF SHEE~

CA 022162~6 1997-09-23 W 096/29025 PCT~NZ96/00024 In preferred embodiments of the present invention the retention apparatus is located towards the leading end of the device to which the retention apparatus is attached.
Locating the retention ~pa,~us at the leading end of the device is a configuration which is frequently adapted and found to be practically suited for insertion of the device into or 5 through a passage leading to an animal' s body cavity, such as the vagina.
In some embo-lim~ntc of the present invention the retention apparatus may be located at the trailing end, each end, or at any point along the body of the device to which the retention apparatus is attached, depending on the method of insertion of the device, and the passage or body cavity into which the device is to be ~tt~'hto.l 10 According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the retention apparatus capable of insertion into a body cavity of an animal includes, multiple arms capable of retaining said device within said body cavity of an animal, characterised in that the arms are sllhst~nti~lly flexible.
lS In preferred embodiments of the present invention the retention apparatus includes multiple arms. Having multiple arms increases the potential points of contact between the retention apparatus and the walls of the animal's body cavity, into which the retention apparatus has been inserted. Increased points of contact contribute to the ability of the retention apparatus to remain in the applvpliate passage or body cavity, without being 20 dislodged by the animal's internal perict~ltic movements.
In some embodiments of the present invention the number of arms of the retentionapparatus may vary, depending on the passage or body cavity into which the device is to be inserted and any corresponding peristaltic movements within the passage or body cavity.
25 In preferred embodiments of the present invention the retention apparatus is made of polymer plastic materials, such as HytrelTM. The flexibility of this material is an important consideration, as it is able to be compressed or subjected to tensile stress without the shape becoming distorted. The ability of this polymer plastic material to revert to its original shape is known as "compressive creep modulus". In addition, this 30 material is durable, it does not crack when bent, has smooth surfaces after moulding which seems to decrease risks of conr~min~tion to the animal, is capable of being moulded, capable of being sterilised for hygienic reasons, is lightweight, chemically resistant, can withct~n~l wet environments, and is economical.

SUBSTITUTE SHEET

CA 022162~6 1997-09-23 W O 96/29025 PCT~NZ~G~C24 However, in other embodiments of the present invention the retention apparatus may be made of other m:~tP.ri~l.c, such as rubber, or a material which is capable of degrading after a known period of time. The use of a degradable material for the retention apparatus could be used to enable devices for which the func~ional utility has been exhzlllcted to be 5 more easily removed from a body cavity or passage of an animal.
In plefell~;d embodiments of the present invention the arms of the retention app~dlus are substantially flexible. The s-lbst~nti~l flexibility of the arms of the retention ap~aldlus enables the arms to flex in both a vertical plane and a horizontal plane in response to changes in the size of the animal's body cavity due to int~-.rn:~l peristaltic waves. Thus the 10 arms are capable of rem~ining in contact with the internal walls of the animal's body cavity without the arms of the retention apparatus snapping or becoming permanently bent. Accordingly, after the peristaltic wave has passed, the substantially flexible arms are capable of lelull~ g to their original shape.
In other embollim~ntc of the present invention the degree of flexibility of the arrns of the 15 retention aL,~alus may be varied in response to the conditions existing within the body cavity into which the retention ap~dlus is to be inserted.
According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the arms of the retention aL)~dlus include a body portion and a distal portion.
20 In preferred embodiments of the present invention each arm of the retention apparatus in~hldec a body portion and a distal portion.
For ease of reference the body portion and the distal portion of the arms of the retention apparatus shall now be referred to as the shaft and the tip, respectively. Although, it should be appreciated that these terms are not int~-.nded to be limiting.
25 In preferred embodiments of the present invention the shaft of each arm is substantially elongate. Substantially elongate shafts enable the retention apparatus to engage with walls of a body cavity of an animal. Engagement of the arms of the retention apparatus with the walls of the animal's body cavity enables the arms of the retention apparatus to maintain contact with the walls of the body cavity throughout changes to the dimensions 30 of the body cavity in response to peristaltic waves moving through the musculature of the walls of the body cavity. Those peristaltic waves otherwise cause the retention apparatus to be dislodged.

SUBS~lTUl'E S~EEl' CA 022162~6 1997-09-23 W 096/29025 PCT~Z96/00024 In other embodiments of the present invention the shafts of the arms of the retention a~pa dlUS may be extendible telescopically. Telescopic extension of the arms may enable the arms of the retention apparatus to be adapted to suit a range of sizes of body cavities or passages into which the retention apparatus may be inserted.
5 In ~l~fellc~d embo~lim~ntc of the present invention the shaft of each arm of the retention aL~dLUS has a cllhst~nti~lly limited cross-sectional ~limPncion.
For ease of lcfel~llce the substantially limited cross-sectional feature of the shaft of each arm of the retention apparatus shall now be referred to as thin, although the use of this term is not inten(le~l to be limiting 10 A thin shaft enables the retention apparatus to have multiple arms, which enhance the retention capability of the device without the shafts of the arms impeding the flow of body secretions. An unimpeded flow of body secretions is nPcecszlry for the normal biological functioning of an animal's reproductive system, digestive system, and so forth.
In some embo~limentc of the present invention however, the shaft of each arm of the 15 retention apparatus may be thicker, or the arms may have varying cross-sectional ~limPncions, depending on the strength of the peristaltic waves in the body cavities into which the retention apparatus is inserted and depending on the types of body secretions present in the dirÇelell~ body cavities of an animal.
In p.er~ d embodiments of the present invention the shaft of each arm of the retention 20 apparatus is substantially circular. Having a substantially circular shaft avoids the possibility of sharp edges causing irritation of the interior walls of the animal's body cavity. In addition, cllhst~nti~lly circular, thin shafts are inherently stronger than thin, flat shafts or lobes, for example, and are more capable of withstanding the forces of the intern~l peristaltic waves within the animal's body cavity. Further, a rounded surface is 25 less likely to impede flows of body secretions to the same extent that a flat surface might.
However, in other embodiments of the present invention, the shafts may be flat, V-shaped, U-shaped, hexagonal, and so forth, depending on the internal conditions of the body cavity into which the retention apparatus is inserted, and the corresponding shaft strength required.

~;UBSTi I UTE SHEET

CA 022162~6 1997-09-23 In pl~er~lled embodiments of the present invention the arms of the retention a~?pd,~us are substantially straight. Straight arms may enable the arms of the retention apparatus to be more compactly aligned with the body of the device, for easier insertion into an animal' s body cavity. Although, in other embodiments the arms may be curved, ~m~ ting, and 5 so forth, to meet the particular needs associated with dirre~ t body cavities.
According to another aspect of the present invention there is provided a substance delivery device subst~nti~lly as described above whelt;ill the distal portions of the arms of the retention apparatus have a substantially greater cross-section than the body portion.
In preferred embodiments of the present invention the tip of each arm of the retention 10 apparatus has a substantially greater cross-sectional ~liml~n~ions than the shaft of the arm.
The greater cross-sectional ~iim~onCion of the tip provides a greater surface area for the arm to contact the intern~l walls of the animal's body cavity, than would be available if the tip retained the same cross-sectional ~iim-on~ion of the shaft. The greater the contact with the body cavity walls, the better the retention of the apparatus, and of the device to which the 15 retention apparatus may be attached, within the animal's body cavity. In addition, the greater cross-sectional tlim~n~ion of the tip is capable of retl-lcing the likelihood of injury to the animal, that might otherwise occur where a thin shaft contacts the soft tissue.
However, in other embo(limcntc of the present invention, where it is necessary for the shaft of the arm of the retention app~dLus to be thicker to compensate for stronger internal 20 peristaltic waves of the animal's body cavity, the tip and the shaft of the arm of the retention apparatus may have the same cross-sectional dimension. In addition, in other embodiments only some of the tips of the arms of the retention apparatus may have greater cross-sectional dimensions, depending on the number of arms of the retention apparatus, and/or body cavity into which the retention apparatus is inserted.
25 In preferred embodiments of the present invention the tip of each arm of the retention apparatus is substantially bulbous. The rounded surface of the substantially bulbous tip is capable of increasing the surface area of contact between the retention apparatus and the internal walls of the animal's body cavity, thereby improving the potential retentive ability of the retention apparatus. In addition, the rounded edges of the bulbous tip obviates 30 problems of irritation of, or injury to, the internal walls of the animal's body cavity~
which may occur with tips that have sharper edges.
In other embodiments of the present invention the tip of each or any arm may be flattened so as to be substantially perpendicular to the shaft, or may be substantially tapered. and so forth. depending on the internal structure of the body cavity into which the retention 35 apparatus is inserted. I l SUBS~l~U~E SHEET

CA 022162~6 1997-09-23 According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the arms of the retention app~Lus are capable of being substantially aligned with each other and the longit-l-lin~l axis of the body of the substance delivery device to which the retention apparatus is S attached, for ready insertion or withdrawal of said substance delivery device into a body cavity of an animal.
According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the arms of the retention apparatus are capable of being aligned substantially parallel to the body of the substance 10 delivery device to which the retention apparatus is attached, ready for insertion or withdrawal of said substance delivery device into or from a body cavity of an animal.
According to another aspect of the present invention there is provided a method of inserting into and withdrawing from a body cavity of an animal, a substance delivery device substantially as described above.
15 In one preferred embodiment of the present invention the arms of the retention apparatus are capable of being aligned substantially parallel to the body of a device required to be inserted into an animal's body cavity. ~li~nm~.nt of the arms subst~nti~lly parallel to the body of the device enables the device and retention apparatus to be more easily inserted into an animal's body cavity through a passage, or be inserted for retention within a 20 passage, such as the vagina. When the arms of the retention apparatus are on the leading edge of the device, pressure of the walls and the opening of a passage way or of an animal's body cavity may be relied on to m~int~in the arms in a parallel arrangement with the body of the device. Insertion of the retention app~tus and the device configured in this way, obviates problems of having to hold the arms of the retention device together to 25 avoid the arms splaying out during insertion, as would be required if the arms protruded forward of the device.
Alternatively, an applicator or even the p~rk~ging of the device, may be used to align the arms parallel to the body of the device.
In another preferred embodiment of the present invention the arms of the retention 30 apparatus are capable of being substantially aligned with each other and the longitudinal axis of the body of the device to which they are attached. Again, this alignment of the arms of the retention apparatus with the body of the device allows the device and retention apparatus to be more easily inserted through or into a passage way or into an animal's SUE~STl~lJTE ~HFET

CA 022162~6 1997-09-23 W 096/29025 PCT~NZ96/00024 body cavity. The retention apparatus may rely on some initial pressure applied by an operator's hands to m~int~in ~lignment of the arms of the retention apparatus prior to insertion into the animal. As insertion commences, the pressure of the walls of the passage way or opening of the animal's body cavity will maintain the arms in a S lc ngit~l~lin~lly aligned position.
~lt.o.rn~tively, where the retention apparatus and device are to be specifically inserted into a passage such as the vagina of an ~nim~l, a removable band may maintain the longitudinal alignment of the arms of the retention apparatus. On insertion of the retention apparatus and device, the removable band may roll back down the arms of the 10 retention apparatus to rest on a portion of the body of the device.
In addition, an applicator may be used to align the arms with each other along the lon~itllAin~l axis of the body. The applicator may be specifically designed for use with the retention a~alaLus and device required to be retained in an animal's body cavity, or may merely be the p~ ging in which the retention appa d~us and device are supplied.
15 In preferred embodiments of the present invention the retention apparatus is capable of being removed from the passage or body cavity of an animal. Once the functional utility of the device to which the retention apparatus is attached has been exhausted, the device may be withdrawn assisted by the pressure exerted by the walls of the passage or the opening to the body cavity. The pressure, in combination with the substantial flexibility 20 of the arms of the retention appaldLLls, enables the arms to become aligned with each other and to the longitudinal axis of the body of the device, or aligned substantially parallel to the body of the device. The device may then be withdrawn with minimllm discomfort to the animal.
According to another aspect of the present invention there is provided a substance 25 delivery device substantially as described above wherein the arms of the retention a~l~aldLLls are capable of being extended for ret~ining the substance delivery device within a body cavity of an animal into which said device is inserted.
According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the arms of the retention 30 apparatus are operable between either an aligned inserting or an aligned withdrawal position and an extended retaining position.
According to another aspect of the present invention there is provided a method of operating multiple arms of retention apparatus of a substance delivery device substantially as described above, between an aligned inserting configuration and an extended retaining 35 configuration. 13 SUBST1TUTE Sl-IFET

CA 022162~6 1997-09-23 In preferred embo-lim.-nt~ of the present invention the arms of the retention apparatus are capable of being operable between an aligned inserting position and an çxtton~l~(l ret~ining posltlon.
In a ~lcf~lled embodiment of the present invention the end of the shaft opposite the tip of 5 each arm of the retention apparatus is moulded to the body of the device form a substantially resilient hinge at that junction between the arm of the retention appaldlus and the body of the device. The resilient hinge enables the arms of the retention apparatus to be more closely aligned to the body of the device, for insertion of the retention apparatus into a body cavity or passage of an animal. In addition, after insertion, the subst:lnti~lly 10 resilient hinge enables the arms of the retention a~al~lus, in conjunction with locking a~paldlus, to assume the extçncle-l ret~ining position of the retention apparatus.
In some emborlim.-nt~ of the present invention other hinges known in the prior art may be adapted for use with the present retention apl)aldlus.
In another preferred embodiment each arm is completely moulded onto the body of a 15 device. In this configuration of the retention apparatus the substantially flexible arms of the retention apparatus are capable of being flexed to enable the arms to be aligned for insertion of the retention apparatus into an animal's body cavity. After insertion, the substantially flexible arms of the retention apparatus are able to assume their extended ret, ining position.
20 According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the arms of the retention apparatus are capable of being locked in an extended ret~ining position.
According to another aspect of the present invention there is provided locking apparatus capable of locking the arms of the retention apparatus of a substance delivery device, 25 subst~nti~lly as described, above in a ret~ining position.
According to a further aspect of the present invention there is provided locking apparatus for retention apparatus of a substance delivery device substantially as described above wherein said locking apparatus includes either one or both of biasing apparatus and plunging apparatus.
30 In preferred embodiments of the present invention the arms of the retention apparatus are capable of being m~int~ined in an extended retaining position by the action of lockin~
apparatus.

SUBSTITUTE SHEET

CA 022162~6 1997-09-23 W O 96/29025 PCT~NZ96/00024 In ~lGfcllGd emboAim.ont~ of the present invention the locking apparatus in~ln~5 either or both of biasing apparatus and plunger apparatus. However, a number of locking a~aldtus exists in the prior art and may be adapted for use with the retention ~p~dLus.
For ease of reference the biasing a~p~dlu~ and plunger apparatus shall now be referred to 5 as a spring-loaded collar and plunger apparatus, respectively, although it should be appreciated that these terms are not to be seen as limiting In preferred emboAim~nt~ of the present invention the spring-loaded collar is capable of operating between a biased position and an unbiased position. When the retentionapparatus is in its inserting position the spring-loaded collar is cocked in its biasing 10 position by the alignment of the arms of the retention apparatus. At a point during the process of insertion, removal of the pressure required to align the arms of the retention apparatus with the device, enables the arms to move towards the extended retaining position. This initial movement of the unrestrained arms causes the spring-loaded collar to be activated.
lS On activation the spring-loaded collar moves in a direction towards the junction where the arms of the retention apparatus meet the device, and in a direction which is substantially in line with the longitllAin~l axis of the device to which the retention appaldllls is attached.
In embodiments which includes a plunger, the plunger is open when the arms are in the inserting position, when the spring-loaded collar is activated the plunger is closed.
20 Accordingly, the arms of the retention appaldlus are thereby held in the extended ret~ining position by either or both of the spring-loaded collar and the plunger apparatus.
In preferred emboAim~-nt~ of the present invention the spring-loaded collar and plunger are incorporated into the leading edge of the device capable of insertion into an animal's body cavity. However, in other embo-lim~--nt~, the spring-loaded collar and plunger may 25 be located at the trailing end of the device. ~Itern~tively, the spring-loaded collar may be located at points along the body of the device, in conjunction with the retention apparatus located at that location.
According to another aspect of the present invention there is provided a substance delivery device substantially as described above wherein the arms of the retaining 30 apparatus occupy a plane substantially perpendicular to the body of the substance delivery device inserted into a body cavity of an animal when locked in an extended retaining position.

SUBSTITUT~ SHEET

CA 022162~6 1997-09-23 W 096/29025 PCT~Z96100024 According to another aspect of the present invention there is provided retention a~ us substantially as described above wherein the arms of the retention apparatus attain a substantially radiai arrangement when said arms are locked in an extended retaining position.
5 In p1~r~;11.;d emborlimt-nt~ of the present invention the arms of the retention apparatus are locked into a substantially radial arrangement around the portion of the body of the device to which the retention a~aldLus is attached, when the arms are in the extended ret~ining position.
In preferred embo-lim~nt~ of the present invention the spring-loaded collar of the retention lO apparatus operates to lock the arms of the retention apparatus in a plane substantially perpendicular to the body of the device inserted into the body cavity of an animal. This arrangement enables the device, to which the retention apparatus is attached, to operate unimpeded by the walls of the body cavity into which the device has been inserted.
Where such devices release an active ingredient, the retention apparatus m~int~in.~ the lS device in a position whereby the active ingredient released from the body of the device, may be free to mix with applu~liate bodily secretions, or be absorbed through the walls of the body cavity into which the device has been inserted.
According to a further aspect of the present invention there is provided delivery apparatus for delivering a substance to an outlet of a substance delivery device substantially as 20 described above wherein the delivery apparatus includes at least one conduit capable of cont:~ining the substance, at least one pressure device capable of applying pressure to the conduit, and valve means characterised by application of pressure by the pressure device and activation of the valve means causing the substance within the conduit to move along the conduit to the outlet.
25 According to a further aspect of the present invention there is provided a method for delivering a substance to an outlet of a substance delivery device substantially as described above including at least one conduit capable of cont~ining the substance, at least one pressure device capable of applying pressure to the conduit and valve means,characterised by the steps of applying pressure to the conduit and valve means. causing 30 the substance within the conduit to move along the conduit to the outlet.
The delivery apparatus itself may take many forms as long as it can be controlled to actively deliver the substance. The mechanism by which the delivery apparatus actively introduces the substance is via a pressure device, and/or valve means SUBSTITUTE SHFET

CA 022162~6 1997-09-23 W O 96/29025 PCTnNZ96/00024 The term s~lbstz~nre used in this specific~tion shall mean any substance including liquid or gas.
The term pressure used in this specification shall mean the application of force, and the term pressure device shall include any mech~nicm used to apply force (such as a pump or 5 spring and plunger system).
~ The term conduit used in this specification shall mean any apparatus capable of conveying a substance and may in some in~t~nres be a reservoir.
The flexible conduit may be divided into two ends. One end, hereinafter referred to as the inlet, is connected to the substance source. The opposite end, hereinafter referred to as 10 the outlet, is connected to the outlet of the delivery apparatus, of the substance delivery device.
The term valve used in this specific~tion shall mean any means, including automatic or other device, used to apply force to, or capable of conveying, a substance from the conduit to the outlet. In some embodiments the valve means may be ~;lirrelc;nt from and/or 15 replace one or all of alternate pressure devices.
The term armature used in this specification shall mean any ~ ald~us of suitable m~t~ri~l, capable of being treated, or capable of responding to a m~gn~-tic or other force field, and when placed in the vicinity of a magnet or other force, has its operational capability increased.
20 The term coil member used in this specification shall mean any apparatus capable of responding to an energy supply, such that a magnetic field, or other force field is created in the vicinity of the coil member.
In conventional substance delivery devices for use inside bodies or other such environments the substance is passively delivered by the natural process of osmosis, 25 diffusion, or dissolution. The rate and volume of substance delivery are determined by the natural processes. Thus, the rate and volume of substance delivery cannot becontrolled or varied by artificial means. It is believed that the pressure devices and/or valve means provide a means of actively delivering the substance. Active delivery of a substance provides a means of controlling the rate and volume of the substance delivered.
30 In one preferred embodiment the valve means is a metering valve system, which operates on a reversed magnetic polarity principle, and includes a moving and a fixed armature.
Preferably, the armatures are made from materials capable of being m~gne~ised.

SU~3STITUTE S#EET

CA 022162~6 1997-09-23 W 096/29025 PCTA~Z96/00024 The metering valve system also preferably includes a coil member which is capable of being activated. On activation of the coil member, a solenoidal effect is produced which causes the moving ~rTn~tl-re to be attached to and seal against the stationary ~rTn~tllre.
Deactivation of the coil member enables the moving ~rm~tllre to move away from the S fixed armature.
In plefell~d embodiments the structural configuration of the metering valve system creates a chamber within the conduit. Accordingly, movement of the moving ~rrn~tllre towards and away from the fixed ~rm~tnre enables some of the substance which haspassed into this chamber to move along the conduit to the outlet.
10 The metering valve system also preferably incorporates tension apparatus, such as a spring, to ensure that the valve system is able to reliably seal, when required.
According to another aspect of the present invention there is provided delivery apparatus for delivering a substance to an outlet of a substance delivery device substantially as described above wherein the delivery apparatus inclucles at least one flexible conduit 15 capable of cont:~inin~ the substance, at least one pressure device capable of applying pressure to the flexible conduit at variable points along the conduit, characterised by the application of pressure by the pressure device causing the substance within the conduit to move along the conduit to the outlet.
According to a further aspect of the present invention there is provided a method for 20 delivering a substance to an outlet of a substance delivery device substantially as described above, including at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit at variable points along the conduit characterised by the step of using the pressure device to apply pressure to the conduit causing the substance within the conduit to move along 25 the conduit to the outlet.
According to a further aspect of the present invention there is provided a method of delivering a substance to a body characterised by the step of using delivery apparatus and/or method as previously described.
The action of the delivery apparatus in delivering the substance shall now be referred to as 30 peristaltic.
While in one embodiment there may be one or two pressure devices, in another preferred embodiment there are three pressure devices.

SUBSTITUTE SHEET

CA 022162~6 1997-09-23 In the alternative preferred embodiment the three pressure devices are positioned sequentially along flexible conduit.
The first pressure device may be located closest to the inlet. The second pressure device may be located between the first pressure device and the third pressure device. The third 5 pressure device is located closest to the outlet.
When the first pressure device applies pressure to the conduit the substance is pushed along the flexible conduit by the application of pressure. The substance is moved as a consequence into the vicinity of the second ~reS:iule device. The pressure from the first pressure device remains applied. The second pressure device then applies pressure 10 causing the substance to be moved further along the flexible conduit and into the vicinity of the third pressure device. The first pressure device may be released. The third pressure device may then apply pressure moving the substance towards the outlet. This sequence may be continued to move sufficient substance out of the delivery apparatus of the delivery device as required.
15 Releasing one pressure device after the next pressure device in the sequence has been applied ~lev~ flow back and ensures that the flow of the substance towards the outlet C~ ntinlles The pressure devices may be controlled by any controlling mechanism such as a micro-processor.
20 The pressure devices which operate as described above are capable of controlling the flow of substance through the flexible conduit. Conventionally, conduits require valves to prevent back flow. The capability of the pressure devices to control the flow of substance removes any need for separate valves to prevent such back flow.
In some embo~lim~ont~ of the present invention the conduit may be greater in length and 25 there may be two or more sets of three pressure devices.
According to a further aspect of the present invention there is provided a substance delivery device substantially as described above, wherein a delivery device for delivering a substance to an outlet including at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit 30 at variable points along the conduit, characterised by the application of pressure by the pressure device causing the substance within the conduit to move along the conduit to the outlet, wherein the pressure device is composed of a piezo pump or a combination of piezo pump and any other type of pump.

SU~3STITUTE SHEET

CA 022162~6 1997-09-23 Piezo pumps contain crystals move upon the application of electrical current. These can be quite small devices which can be controlled to a high degree of accuracy. As the operation of the piezo pump is dependent on current only, few moving parts are required and the construction is simple.
S In p,erelled embodiments there are three piezo electric pumps, but there may be any number.
For ease of reference the pressure devices shall now also be referred to as pumps.
However, it should be appreciated that use of this term is not int~.ntl~-~l to be limiting.
Piezo pumps are small in the pl~;felled embodiment, having a ~ m~t~r of 6.4 rnillimetres 10 at their widest point and a length of 12 millim.-tres. Thus, piezo pumps are well suited to delivery devices where space is limited, such as inside bodies.
Piezo pumps are economical pressure devices which have a low power draw and thel~rol~ can be readily battery powered.
According to a further aspect of the present invention there is provided a means of 15 utilising energy sources in the surrounding environment. The energy sources may include kinetic, chemical, or thermal energy.
It can be seen that the present invention has a number of advantages over the prior art.
The pressure devices are small, simple, and require little maintenance, and are thus suitable to pit inside bodies or other such environments.
20 According to another aspect of the present invention there is provided a method of introducing a substance into an animal from a substance delivery device substantially as described above, characterised by the step of controlling the operation of the delivery apl~aldL~Is so that the substance is actively introduced into the animal.
The pump and/or valve means of the delivery aL~l~aldtLIs may be controlled by a variety of 25 means. In preferred embodiments, the means of control is a microprocessor. It should be appreciated however that other control mech~ni~m~ such as an 'ASIC' (Application Specific Integrated Circuit) may be used.

-CA 022162~6 1997-09-23 The advantages of having active control over the introduction of the substance is readily a~a c;ll~. The pressure devices are actively operated by the controlling mech~ni~m and thus the rate and volume of substance delivered may be controlled. Accordingly, active delivery means that there is greater control so that the precise concentration of the S substance can be delivered at the precise time, independent of the environment surrounding the substance delivery device, or delivery a~p~us.
The means by which the microprocessor can control this pump can vary. The pump may be powered by an energy source (perhaps a battery, an external source such as the animal's body, a magnetic field, a spring or the like) and the action of the microprocessor 10 may be merely to connect or disconnect the pumps from the energy source.
Alternatively, the microprocessor may control the valve or valves which permit or prevent the flow of substance from the delivery a~pal~tus, and substance delivery device.
In one embodiment of the present invention, the microprocessor may be programmed to control the release of varying doses of differing hormones into the animal at 15 predetermined times, thus allowing for accurate c1eterrnin:~tion of when oestrus occurs.
According to a further aspect of the present invention there is provided a method of controlling the delivery ap~.~aLus of a substance delivery device ~ubst~nti~lly as described previously characterised by the step of introducing predet~rrnin~d amounts of substance at predetermined times into the body of an animal.
20 There are further advantages of having an active control delivery of substance to an animal. For example, there may be provided sensors which monitor the environmentaround the substance delivery device or delivery apparatus. The sensors may determine when the environment is ideal for the introduction of a substance into the body of the animal. This information may be then acted upon by the microprocessor to control the 25 delivery a~ala~us to introduce those substances.
For example, the sensors could determine factors in the body fluid surrounding the substance delivery device and/or delivery apparatus, such as temperature, acidity.
viscosity or even odour. These physiological indicators may in some instances be more accurate than a calendar date for determining when certain substances should be 30 introduced into the animal. With active control, an accurate response to these physiological conditions is possible.
In some embodiments of the present invention the microprocessor may actuallv alter the size of the dose as well as the timing depending upon the environment the device is in.

SUE~STITUTE SHEET

CA 022162~6 1997-09-23 In other embo-lim~nt.c of the present invention the action of the delivery a~p~lus may be remotely activated. For example, the device may remain inactive within the animal for a period of time until the farmer wishes to start the fertility cycle. At which stage, the farmer may have an external device to the animal which triggers the action of the delivery 5 apparatus or wakes up the microprocessor. This external device may come in many forms, for example it may be a radio tr~ncmittcr, an ultrasonic tr:~ncmitt~r, a magnet and so forth.
In some embodiments of the present invention, remote programming of the microprocessor may be possible from outside the animal or at time of insertion.
10 In other embodiments of the present invention the microprocessor may be able to commlmiç~t~ to an extern~l device. For example, the microprocessor may feed back data as to how much substance has been delivered, the telllpGldLul~ of the environment and so forth.
An a~piopliate microprocessor for use with the present invention is a four bit microprocessor or an 8 bit single chip microprocessor such as a pic 16c54 or Z8 or Motorola 6805.
It should be appreciated that although reference throughout this specification has been made to the use of the present invention as a substance delivery device or delivery apparatus for use within :~nim~lc, the delivery apparatus, control mech:~nicmc, and 20 retention apparatus described may be used in substance delivery devices in other environments, particularly in environments which it is not possible to directly access the substance delivery device.
BRIEF DESCRIPTION OF DRAWINGS
Further aspects of the present invention will become apparent from the ensuing 25 description which is given by way of example only and with reference to the accompanying drawings in which:
Fi~ure 1 is a diagrammatic perspective view of a retention apparatus in accordance with one embodiment of the present invention, and Figure 2 is a diagrammatic perspective view of a retention apparatus in accordance with another embodiment of the present invention, and Figure 3 is a diagrammatic top plan view of a retention apparatus in accordance with another embodiment of the present invention, and ,. .~

SUBST~TUTE SHEET

CA 022162~6 1997-09-23 W O 96/29025 PCTA~Z96/00024 Figure 4 is a diagr:~mm~tic cross section of the retention a~palaLlls in Figure 3, in accordance with that embodiment of the present invention, and Figure 5 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with one embodiment of the present invention, and S Figure 6 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and Figure7 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and Figure 8 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and Figure 9 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and Figure 10 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and lS Figure 11 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and Figure 12 is a diagr~mm~tic cross-sectional view of a retention apparatus in accordance with another embodiment of the present invention, and Figure 13 is a diagr~mm~tic view of a peristaltic device fltted in accordance with one embodiment of the present invention, and Figure 14 is a view of the pressure device action on the flexible conduit, and Figure lS is a diagr~mm~tic view of a delivery apparatus which can be used in accordance with one embodiment of the present invention, and Figure 16 is a diagr~mm~tic view of a valve of a delivery apparatus used inaccordance with a preferred embodiment of the present invention, and Figure 17 is a diagrammatic cross-sectional view of a delivery apparatus used inaccordance with a preferred embodiment of the present invention, and Figure 18 is a diagrammatic view of an open valve of a delivery apparatus used in accordance with a preferred embodiment of the present invention, and ~)3 SUBSTITUTE SHEET

CA 022162~6 1997-09-23 w 096/2902S PCTANZ96/00024 Figure 19 is a diagr:~mmzttic view of a closed valve of a delivery apparatus used in accordance with a ple~llcd embodiment of the present invention, and Figure 20 is a graphical representation of a possible cycle which can be initi~tecl with the present invention.
BEST M ODES FOR C ~RRYING OUT THE INVENTION
With reference to the diagrams by way of example only there is provided substance delivery device generally in~ te.cl by arrow 1. The substance delivery device 1 includes retention apparatus generally indicated by arrow 2. The substance delivery device 1 is capable of insertion into a body cavity or passage of an animal.
10 The retention apparatus 2 includes multiple arms 3 characterised in that the arms 3 are ~ub~La llially flexible.
Figures 1 and 2 are diagrammatic perspective views of the retention apparatus 2 for a device 1 capable of insertion into a body cavity of an animal, according to one embodiment of the present invention.
The multiple arms 3 of the retention apparatus 2 are substantially straight, thin and substantially circular to reduce the interference with the normal flow of body secretions, such as mucus in the vagina.
The shaft 4 of each arm 3 is substantially elongate to enable the retention apparatus 2 to engage with the walls of a body cavity of an animal. The tip 5 of each arrn 3 has a 20 substantially greater cross-sectional ~limen~ion than the shaft 4 of the arm 3. In preferred embodiments, the tip 5 is substantially bulbous which obviates problems of irritation of the internal walls of the animal' s body cavity.
The arms 3 of the retention apparatus 2 are s~lbst~nti~lly flexible, which enables the arms 3 to be aligned for insertion into the body cavity of an animal, and also enables the arrns 3 2~ to withstand the forces of the internal peristaltic waves within the body cavity of the animal. The substantial flexibility of the arms 3 enables the arrns 3 to bend in response to the peristaltic waves without breaking, and enables the arms 3 to return to their fully extended ret~inin" position once the peristaltic waves have passed.
~)4 SUBSTlTUTE SHEET

CA 022162~6 1997-09-23 The arms 3 of the retention apparatus 2 are moulded as an integral part of the body of a device 1 to which the retention apparatus 2 is attached. In one preferred embodiment the arms 3 of the retention apparatus 2 are resiliently hinged 6 at the junction 7 between the shaft 4 of the arm 3 and the body of the device 1 (as in Figures 7 to 10 inclusive). Or in S another preferred embodiment, the arms 3 are completely moulded to the body of the device 1 (as in Figures 5, 6, 11 and 12).
The arms 3 of the retention ~a dlus 2 are operable between an aligned inserting position (as in Figures 5, 7, 9 and 11) and an extended retaining position (as in Figures 6, 8, 10 and 12). In the inserting position, the arms 3 are capable of being aligned substantially 10 parallel to the body of the device 1 as shown in Figures S and 7. Alternatively, in other preferred embo-lim~nts the arms 3 of the retention apparatus 2 may be aligned with each other and the longitu-linz-l axis of the device 1, as in Figures 9 and 11.
The arms 3 of the retention apparatus 2 are capable of being locked into the extended ret~ining position by the action of a spring-loaded collar 8. When the retention apparatus 15 2 is in its inserting position, the spring-loaded collar is cocked, as shown in Figures 5, 7, 9 and 11. During the process of insertion, when pressure is no longer applied to the arms 3 by an operator, an applicator, or the walls of the opening of the passage or body cavity into which the device is inserted, the arms 3 of the retention apparatus 2 are capable of moving towards the extended retaining position. This movement of the arms 3 activates 20 the spring-loaded collar 8 to move in a direction substantially in-line with the longitudinal axis of the body of the device 1, and towards the arms 3. The spring-loaded collar 8 may operate in conjunction with the resiliently hinged arms 3 as in Figure 8, or in conjunction with the substantially flexible arms 3, as in Figure 6; by the action of the spring-loaded collar 8 in conjunction with a plunger 9 and resiliently hinged arms 3 as in Figure 10, or 25 by the action of a spring-loaded collar 8 in conjunction with plunger 9 and the substantial flexibility of the arms 3, as in Figure 12.
The spring-loaded collar 8 operates to lock the arms 3 of the retention apparatus 2 in a plane substantially perpendicular to the body of the device l When locked in theextended retaining position the arms 3 of the retention apparatus 2 are located in a 30 substantially radial arrangement around the body of the device l as in Figures l and ''.

SUBS~lTUTE SHEET

CA 022162~6 1997-09-23 Removal of the retention apparatus 2 may be effected by withdrawal of the device 1.
During withdrawal of the subst~nti~lly flexible arms 3 of the retention apparatus 2 may be realigned into a position substantially parallel to, or in line with the longi~ linAl axis of the body of the device 1. This alignment may be achieved through pressure exerted on 5 the arms 3 by the walls of the animal's passage or body cavity through which the device is removed.
With respect to Figure 13 there is illustrated a peristaltic device generally indicated by arrow 10 fitted into a delivery apparatus generally incli~tP.cl by arrow 11.
The delivery apparatus 11 comprises a housing 12 c-)ntzlinin~ reservoirs 13 cont~ining the 10 substances to be delivered by the delivery apparatus 11. The reservoirs 13 have connection lines 14 to three pressure devices in the form of piezo pumps 15.
A flexible conduit 16 leads to the outlet 17 of the delivery apparatus 11. The conduit 16 fits between three piezo pumps 15 and a pressure device controlling mech~ni~m 18.
In this device 1 the controlling mech~ni~m 18 is a microprocessor.
Also inside the housing 12 is an energy source 19 in the form of a battery and an inlet 20 that allows air into the housing 12 preventing the creation of a vacuum.
Figure 14 illustrates the action of the piezo pumps 15 on the flexible conduit 16.
If pressure from each pump 15 is sequentially applied to the flexible conduit 16, the substance 21 is forced along flexible conduit 16. The pumps 15 have restraints 22.
Operation of the present invention may occur as follows. The connection lines 14 may cause substance holding bodies 13 to release substance into the flexible conduit 16. The pressure devices 15 apply pressure to the flexible conduit 16 to move the substance along the flexible conduit 16 to the substance outlet 17.
Figure 15 also illustrates the construction of a delivery apparatus 11. The delivery apparatus 11 has an outer housin~ 12, an active delivery means in the form of a pump 23.
a control means in the form of a microprocessor 18, an energy source in the form of a battery 19, and reservoirs 13 to hold the substances to be delivered.
In this embodiment, the reservoirs 13 are flexible walled and situated near one end of the delivery apparatus 11.
The inlet '~0 comprises a one way valve 13 situated at the end of the housing 1~. The inlet 20 leads into an air space ~4 adjacent the~r6eservoirs 13.

SU~STlTUTE SH E'r CA 022162~6 1997-09-23 W 096/29025 PCT~NZ96/00024 The reservoirs 13 are connected by conduits to the pump 23, wnich in turn is connected to an outlet 17 at the opposite end of the housing 12 to the one way valve 20.
In operation, the pump 13 and the microprocessor 18 are powered by the battery 19. The microprocessor 18 turns on the pump 13 and selects which of the substances in the S reservoirs 13 are to be pumped through the conduits to the outlet 17 at a predetermined time. The pumping action causes air to enter the one way valve 20 and to air space 24.
This allows the flexible wall containers to collapse under the air pressure as the substance is being pumped therefrom.
Figures 16, 17, 18 and 19 illustrates a metering valve 20 of a preferred embodiment of 10 the present invention which operates on a reversed m~,gn~tie polarity principle.
The metering valve 20 consists of a moving armature 25 and a stationary armature 26 The armature 25 and 26 are preferably made out of soft iron or other magnetised material.
In this preferred embodiment, the reservoir 13 contains an active substance to be dispensed. The active substance is dissolved or suspended in a fluid, such that the 15 resultant solution is of a low to modest viscosity, such as is found with weak aqueous solutions, alcohol, or light oil.
The reservoir 13 is pressurised. The pressure may be applied by a number of means, such as a spring and plunger system.
This embodiment relies on activation of a coil member 27. The coil member 27 is 20 preferably operated at a low frequency and at a very low duty cycle. Typically however, the on off times of the coil member 27 will be greater than one second.
When the coil member 27 is activated, a solenoid action occurs. This in turn causes the moving armature 25 to be attracted to the stationary armature 26.
When the coil member 27 is turned off, the magnetising circuit decays. When the 25 magnetising circuit decays, a volume of the active fluid solution which has passed from the reservoir 13 into a dosing chamber 29, and is equal in volume to the displaced tt-r of the moving armature 25, is then pushed out of the outlet 17. The valve 20 includes a disk which acts as a non-return valve. Accordingly, this causes the displaced fluid to be pushed forward when the coil member 27 is de-energised.
30 While the coil member 27 is activated, the moving armature 25 is sealed against the stationary armature 26. This seal prevents the dosing chamber from being refilled from the reservoir 13. Accordingly~ the dosing volume is relatively independent of the fluid reservoir pressure and the operating time of th~e7valve 20.

SUBST~TUTE SHEET

CA 022162~6 1997-09-23 A spring 28 is used to keep the moving armature 25 and the metering valve 20 seated on the outlet 17. The force of this spring 28 needs only be sufficient to ensure that the valve 20 seals reliably.
In some embodiments, metal l~min~tions around the coil member 17 and within the outlet 5 17, may be used to improve the efficiency of the mP.terin~ system.
Preferably, the stationary armature 26 is in contact with the fluid held in the reservoir 13.
Accordingly, a suitable protective coating may be used to protect the stationary armature 26, and also the moving armature 25 from the effects of the fluid being dispensed.
In other embodiments of the present invention the moving armature 25 may be differently 10 configured, to include a flat plate with laser drilled, or chemically milled cavities which form the dosing chamber(s).
Figure 19 illustrates a possible dosing scenario showing different doses of different hormones (indicated by different fill colours) being dispensed over predetermined times with the date of oestrus being positively defined.
15 Aspects of the present invention have been described by way of example only and it should be appreciated that modifications and additions may be made thereto without departing from the scope thereof, as defined in the appended claims.

~8 SUBST~TUT~ ~ItEE'f

Claims (46)

THE CLAIMS DEFINING THE INVENTION ARE:
1. Substance delivery device capable of insertion into a body cavity of an animal, including delivery apparatus, capable of actively being controlled to deliver a substance to an outlet, and retention apparatus capable of retaining the substance delivery device within the body cavity of an animal.
2. Substance delivery device as claimed in claim 1 wherein the retention apparatus is located at at least one end of the substance delivery device.
3. Substance delivery device as described in any one of the preceding claims wherein the retention apparatus capable of insertion into a body cavity of an animal includes multiple arms capable of retaining said device within said body cavity of an animal, characterised in that the arms are substantially flexible.
4. Retention apparatus for a device capable of insertion into a body cavity of an animal which includes multiple arms capable of retaining said device within said body cavity of an animal, characterised in that the arms are substantially flexible.
5. Substance delivery device as claimed in claim 3 wherein the arms of the retention apparatus are capable of being substantially aligned with each other and the longitudinal axis of the body of the substance delivery device to which the retention apparatus is attached, for ready insertion or withdrawal of said substance delivery device into a body cavity of an animal.
6. Substance delivery device as claimed in claim 5 wherein the arms of the retention apparatus are capable of being aligned substantially parallel to the body of the substance delivery device to which the retention apparatus is attached, ready for insertion or withdrawal of said substance delivery device into a body cavity of an animal.
7. Substance delivery device as claimed in any one of the preceding claims wherein the arms of the retention apparatus are capable of being extended to retain the substance delivery device within a body cavity of an animal into which said substance delivery device is inserted.
8. Substance delivery device as claimed in claim 7 wherein the arms of the retention apparatus are operable between either an aligned inserting or aligned withdrawal position and an extended retaining position.
9. Substance delivery device as claimed in any one of the preceding claims wherein the arms of the retention apparatus are capable of being locked in an extended retaining position.
10. Substance delivery device as claimed in claim 9 wherein the arms of the retaining apparatus occupy a plane substantially perpendicular to the body of the substance delivery device inserted into a body cavity of an animal, when locked in an extended retaining position.
11. Substance delivery device as claimed in claim 10 wherein the arms of the retention apparatus attain a substantially radial arrangement when said arms are locked in an extended retaining position.
12. Substance delivery device as claimed in any one of the preceding claims wherein locking apparatus is capable of locking the arms of the retention apparatus in a retaining position.
13. Substance delivery device as claimed in claim 12 wherein the locking apparatus of the retention apparatus includes either one or both of biasing apparatus and plunging apparatus.
14. Substance delivery device as claimed in any one of the preceding claims wherein the arms of the retention apparatus include a body portion and a distal portion.
15. Substance delivery device as claimed in claim 14 wherein the distal portions of the arms of the retention apparatus have a substantially greater cross-section of the body portion.
16. A method for retaining a substance delivery device within a body cavity of an animal into which the substance delivery device is inserted, by use of retention apparatus.
17. A method of inserting a substance delivery device into and withdrawing a substance delivery device from a body cavity of an animal.
18. A method of operating multiple arms of retention apparatus of a substance delivery device, between an aligned inserting configuration and an extended retaining configuration.
19. Delivery device for delivering a substance to an outlet including at least one conduit capable of containing the substance, at least one pressure device capable of applying pressure to the conduit, and valve means, characterised by the application of pressure by the pressure device and activation of the valve means causing the substance within the conduit to move along the conduit to the outlet.
20. Substance delivery device as claimed in any one of the preceding claims wherein delivery apparatus for delivering a substance to an outlet including at least one conduit capable of containing the substance, at least one pressure device capable of applying pressure to the conduit, and valve means, characterised by the application of pressure by the pressure device and activation of the valve means causing the substance within the conduit to move along the conduit to the outlet.
21. Substance delivery device as claimed n claim 20 wherein the valve means of the delivery apparatus operates on a reversed magnetic polarity principle.
22. Substance delivery device as claimed in claims 20 and 21 wherein the valve means of the delivery apparatus includes a magnetised moving armature, a fixed armature, a coil member capable of being magnetised, tension apparatus, and a chamber capable of receiving a substance from a conduit.
23. A method for delivering a substance to an outlet of a substance delivery device, including at least one conduit capable of containing the substance, at least one pressure device capable of applying pressure to the conduit and valve means, characterised by the steps of applying pressure to the conduit and activating valve means, causing the substance within the conduit to move along the conduit to the outlet.
24. Delivery apparatus for delivering a substance to an outlet including at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit at variable points along the conduit, characterised by the application of pressure by the pressure device causing the substance within the conduit to move along the conduit to the outlet.
25. Substance delivery device as claimed in any one of the preceding claims wherein the delivery apparatus for delivering a substance to an outlet includes at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit at variable points along the conduit, characterised by the application of pressure by the pressure device, causing the substance within the conduit to move along the conduit to the outlet.
26. Substance delivery device as claimed in claim 25 wherein the delivery apparatus for delivering a substance to an outlet includes at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit at variable points along the conduit, and characterised by the application of pressure by the pressure device causing the substance within the conduit to move along the conduit to the outlet, wherein the pressure device is composed of a piezo pump or a combination of piezo pump and any other type of pump.
27. Substance delivery device as claimed in claim 26 wherein a sequence of pressure devices operates such that the activity of one pressure device does not cease until the next pressure device in the sequence is activated.
28. Substance delivery device as claimed in any one of the preceding claims wherein the delivery apparatus is powered by an energy source.
29. Substance delivery device as claimed in any one of the preceding claims wherein the action of the delivery apparatus is controlled by a control mechanism.
30. Substance delivery device as claimed in claim 29 wherein the action of the control mechanism of the delivery apparatus is capable of regulating the timing of and volume of substance released from the substance delivery device.
31. Substance delivery device as claimed in claim 30 wherein the control mechanism of the delivery apparatus includes microprocessor(s).
32. Substance delivery device as claimed in claim 31 wherein the control mechanism of the delivery apparatus may be programmed to also respond to environmental changes around the substance delivery device.
33. Substance delivery device as claimed in claim 32 wherein environmental changes around the substance delivery device may be detected via sensors in the substance delivery device.
34. Substance delivery device as claimed in any one of the preceding claims wherein the action of the controlled delivery apparatus may be remotely programmed and operated.
35. A method for delivering a substance to an outlet of a substance delivery device, including at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit at variable points along the conduit, and characterised by the step of using the pressure device to apply pressure to the conduit causing the substance within the conduit to move along the conduit to the outlet.
36. A method of delivering a substance to a body characterised by the step of using delivery apparatus including at least one flexible conduit capable of containing the substance, at least one pressure device capable of applying pressure to the flexible conduit at varying points along the conduit, characterised by the application of pressure by the pressure device, causing the substance within the conduit to move along the conduit to an outlet and into the body.
37. A method of delivering a substance to a body characterised by the step of using a pressure device of the delivery apparatus to apply pressure to the conduit of the delivery apparatus, causing the substance within the conduit to move along the conduit to an outlet and into a body.
38. A method of introducing a substance into an animal characterised by the step of controlling the operation of the substance delivery device so that the substance is actively introduced into the animal.
39. A method of introducing a substance into an animal from a substance delivery device as claimed in any one of claims 21, 36 to 38, characterised by the step of controlling the operation of the delivery apparatus so that the substance is actively introduced into the animal.
40. A method of controlling the delivery apparatus of a substance delivery device as claimed in any one of claims 21, 36 to 39 characterised by the step of introducing predetermined amounts of substance at predetermined times into the body of an animal.
41. A method of controlling the introduction of a substance into an animal from a substance delivery device as claimed in any one of claims 21, 36 to 40, characterised by utilising energy sources in the environment surrounding the substance delivery device.
42. Substance delivery device substantially as claimed herein described with reference to and as illustrated by the accompanying drawings.
43. A method of retaining a substance delivery device within a body cavity of an animal substantially as claimed herein described with reference to and as illustrated by the accompanying drawings.
44. A method of operating multiple arms of retention apparatus of a substance delivery device substantially as claimed herein described with reference to and as illustrated by the accompanying drawings.
45. A method of inserting into and withdrawing from a body cavity of an animal a substance delivery device substantially as claimed herein described with reference to and as illustrated by the accompanying drawings.
46. A method for delivering a substance into a body substantially as claimed herein described with reference to and as illustrated by the accompanying drawings.
CA002216256A 1995-03-23 1996-03-25 Substance delivery device Abandoned CA2216256A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
NZ27079495 1995-03-23
NZ270794 1995-03-23
NZ270806 1995-03-24
NZ27080695 1995-03-24
NZ270876 1995-04-06
NZ27087695 1995-04-06

Publications (1)

Publication Number Publication Date
CA2216256A1 true CA2216256A1 (en) 1996-09-26

Family

ID=27353742

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002216256A Abandoned CA2216256A1 (en) 1995-03-23 1996-03-25 Substance delivery device

Country Status (6)

Country Link
US (4) US6436069B1 (en)
EP (3) EP0990425B1 (en)
AU (1) AU716398B2 (en)
CA (1) CA2216256A1 (en)
DE (4) DE820258T1 (en)
WO (1) WO1996029025A1 (en)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962579B2 (en) * 1995-03-23 2005-11-08 Advanced Animal Technology Limited Substance delivery device
AU716398B2 (en) * 1995-03-23 2000-02-24 Advanced Animal Technology Limited Substance delivery device including a retention apparatus
WO1998033452A1 (en) * 1997-02-03 1998-08-06 Dec International Nz Limited Active delivery device and related procedures
WO1999043269A2 (en) * 1998-02-25 1999-09-02 Bryher Holdings Limited Veterinary delivery device and method
EP1119313A2 (en) * 1998-10-05 2001-08-01 Advanced Animal Technology Limited Improvements in and relating to retention apparatus
NZ336241A (en) * 1999-06-11 2001-12-21 Interag Liquid delivery device, typically in form of bolus, with battery powered circuit to generate gas and move piston to expel gas
NZ337318A (en) 1999-08-18 2002-07-26 Interag Dispensing apparatus for dispensing same or different materials for at least two reservoirs
NZ507800A (en) * 2000-10-26 2003-06-30 Interag Device for herd control and/or monitoring procedures
DE10105592A1 (en) 2001-02-06 2002-08-08 Achim Goepferich Placeholder for drug release in the frontal sinus
NZ517094A (en) * 2002-02-08 2005-03-24 Advanced Animal Technology Ltd Improvements in and relating to substance delivery device
US20030233125A1 (en) * 2002-06-12 2003-12-18 Alfred E. Mann Institute For Biomedical Engineering At The University Of S. California Injection devices for unimpeded target location testing
US20070265582A1 (en) * 2002-06-12 2007-11-15 University Of Southern California Injection Devices for Unimpeded Target Location Testing
US8317816B2 (en) 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
US6929621B2 (en) * 2002-10-02 2005-08-16 Civco Medical Instruments Co., Inc. Drainage catheter with bifurcating tip
NZ523948A (en) * 2003-01-30 2006-08-31 Sensortec Ltd Animal control system
US7682354B2 (en) * 2003-04-01 2010-03-23 Aircom Manufacturing, Inc. Dispenser having piezoelectric elements and method of operation
US20060116640A1 (en) * 2003-04-01 2006-06-01 Trompen Mick A Dispenser having piezoelectric elements and method of operation
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US20070208252A1 (en) 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8146400B2 (en) 2004-04-21 2012-04-03 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
WO2006078672A1 (en) * 2005-01-19 2006-07-27 Baker Randal S Medical agent delivery system and method
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US7954457B2 (en) * 2005-09-14 2011-06-07 Aircom Manufacturing, Inc. Dispenser
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
CN103381284B (en) 2005-10-14 2017-03-01 内诺斯蒂姆股份有限公司 Leadless cardiac pacemaker and system
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US8273071B2 (en) 2006-01-18 2012-09-25 The Invention Science Fund I, Llc Remote controller for substance delivery system
US8083710B2 (en) 2006-03-09 2011-12-27 The Invention Science Fund I, Llc Acoustically controlled substance delivery device
US8936590B2 (en) 2005-11-09 2015-01-20 The Invention Science Fund I, Llc Acoustically controlled reaction device
US7699834B2 (en) 2005-11-09 2010-04-20 Searete Llc Method and system for control of osmotic pump device
US8998884B2 (en) 2005-11-09 2015-04-07 The Invention Science Fund I, Llc Remote controlled in situ reaction method
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
US8992511B2 (en) 2005-11-09 2015-03-31 The Invention Science Fund I, Llc Acoustically controlled substance delivery device
US20070260174A1 (en) * 2006-05-05 2007-11-08 Searete Llc Detecting a failure to maintain a regimen
US8190389B2 (en) 2006-05-17 2012-05-29 Acclarent, Inc. Adapter for attaching electromagnetic image guidance components to a medical device
US7547323B2 (en) * 2006-08-29 2009-06-16 Sinexus, Inc. Stent for irrigation and delivery of medication
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US8439687B1 (en) 2006-12-29 2013-05-14 Acclarent, Inc. Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US8118757B2 (en) 2007-04-30 2012-02-21 Acclarent, Inc. Methods and devices for ostium measurement
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
US10206821B2 (en) 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
US8182432B2 (en) 2008-03-10 2012-05-22 Acclarent, Inc. Corewire design and construction for medical devices
ES2700863T3 (en) 2008-07-30 2019-02-19 Acclarent Inc Devices for localization of the paranasal ostium
WO2010033629A1 (en) 2008-09-18 2010-03-25 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
WO2010088687A1 (en) 2009-02-02 2010-08-05 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US20120095438A1 (en) * 2009-03-02 2012-04-19 Sanofi-Aventis Deutschland Gmbh Medication delivery device with foldable finger pad
US20100241155A1 (en) 2009-03-20 2010-09-23 Acclarent, Inc. Guide system with suction
US7978742B1 (en) 2010-03-24 2011-07-12 Corning Incorporated Methods for operating diode lasers
US8435290B2 (en) 2009-03-31 2013-05-07 Acclarent, Inc. System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
WO2011006067A1 (en) * 2009-07-09 2011-01-13 Ams Research Corporation Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue
US8298185B2 (en) * 2010-09-14 2012-10-30 Suremka Medical, Llc Retractable cannula for surgical procedures
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US8543205B2 (en) 2010-10-12 2013-09-24 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
WO2012051235A1 (en) 2010-10-13 2012-04-19 Nanostim, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
WO2012082735A1 (en) 2010-12-13 2012-06-21 Nanostim, Inc. Delivery catheter systems and methods
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
CN103328040B (en) 2010-12-20 2016-09-14 内诺斯蒂姆股份有限公司 There is the pacemaker without wire of radially fixed mechanism
EP2773416B1 (en) 2011-11-04 2019-04-24 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
US8986337B2 (en) * 2012-02-24 2015-03-24 Elwha Llc Devices, systems, and methods to control stomach volume
US9802054B2 (en) 2012-08-01 2017-10-31 Pacesetter, Inc. Biostimulator circuit with flying cell
CN104661622B (en) * 2012-08-09 2016-11-16 米斯拉制药公司 Intrauterine device
US9999720B2 (en) 2012-09-27 2018-06-19 Palo Alto Research Center Incorporated Drug reconstitution and delivery device and methods
US9005108B2 (en) 2012-09-27 2015-04-14 Palo Alto Research Center Incorporated Multiple reservoir drug delivery device and methods
US9744341B2 (en) * 2013-01-15 2017-08-29 Palo Alto Research Center Incorporated Devices and methods for intraluminal retention and drug delivery
US9433437B2 (en) 2013-03-15 2016-09-06 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9629684B2 (en) 2013-03-15 2017-04-25 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9297083B2 (en) 2013-12-16 2016-03-29 Palo Alto Research Center Incorporated Electrolytic gas generating devices, actuators, and methods
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
SG10201912100SA (en) 2014-06-11 2020-02-27 Massachusetts Inst Technology Residence structures and related methods
US10278675B2 (en) 2014-07-31 2019-05-07 Palo Alto Research Center Incorporated Implantable estrus detection devices, systems, and methods
US9801660B2 (en) 2014-07-31 2017-10-31 Palo Alto Research Center Incorporated Implantable fluid delivery devices, systems, and methods
EP3364946A4 (en) 2015-10-23 2019-06-26 Lyndra, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
JP2019532947A (en) 2016-09-30 2019-11-14 リンドラ,インコーポレイティド Gastric retention system for sustained delivery of adamantane drugs
BR202019016494U2 (en) * 2019-08-08 2021-02-09 Wta - Watanabe Tecnologia Aplicada Eireli - Epp DEVICE FOR SLOW RELEASE OF PROGESTERONE
AU2020328595B2 (en) * 2019-08-14 2023-07-13 Elanco Tiergesundheit Ag New wing protector for winged capsule and method of using same
WO2021222274A1 (en) * 2020-04-27 2021-11-04 Cornell University An automated controlled release device for livestock management and methods of use thereof

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US190350A (en) 1877-05-01 Improvement in faucets
US2735804A (en) 1956-02-21 Stack
US230023A (en) 1880-07-13 Seal-lock
US228382A (en) 1880-06-01 Charles w- page
US215483A (en) 1879-05-20 Improvement in cider-presses
US207341A (en) 1878-08-27 Improvement in car-couplings
US215635A (en) 1879-05-20 Improvement in horse hay-rakes
US200564A (en) 1878-02-19 Improvement in clock striking-movements
US173808A (en) 1876-02-22 Improvement in machines for flanging boiler-heads
US193976A (en) 1877-08-07 Improvement in button-fastenings
US3628530A (en) * 1969-03-24 1971-12-21 Jerome Schwartz Intrauterine device for contraception
US3656483A (en) * 1970-01-15 1972-04-18 Biolog Concepts Inc Intrauterine medicator
US3811443A (en) 1971-01-22 1974-05-21 Agrophysic Inc Method and apparatus for artificial insemination
IE35992B1 (en) 1971-01-22 1976-07-21 Agrophysics Inc Device for insertion into the reproductive tract and metho
US3811423A (en) 1971-01-22 1974-05-21 Agrophysics Inc Device for insertion into the reproductive tract and method of using same
US3892842A (en) 1971-09-01 1975-07-01 Alza Corp Intrauterine contraceptive device for releasing steroid having double bond functionality
US3929984A (en) 1971-11-22 1975-12-30 Alza Corp Intrauterine device and method for releasing pharmaceutically acceptable contraceptive heterogenous compounds
US3895103A (en) 1971-11-22 1975-07-15 Alza Corp Intrauterine contraceptive device containing certain pharmaceutically acceptable steroids
US4188951A (en) 1972-08-17 1980-02-19 Alza Corporation Intrauterine system embracing selected copolymeric membranes for administering beneficial agent
US4016251A (en) 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3971367A (en) * 1972-12-27 1976-07-27 Alza Corporation Intrauterine device having means for changing from uterine-retentive shape to nonuterine-retentive shape
US3888975A (en) * 1972-12-27 1975-06-10 Alza Corp Erodible intrauterine device
US4003379A (en) * 1974-04-23 1977-01-18 Ellinwood Jr Everett H Apparatus and method for implanted self-powered medication dispensing
US4014987A (en) 1974-06-04 1977-03-29 Alza Corporation Device for delivery of useful agent
US4091807A (en) 1976-11-04 1978-05-30 Dickinson Ben Wade O Iii Intra-vaginal device and method of use
AU520409B2 (en) 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
US4258711A (en) 1979-02-05 1981-03-31 Metal Bellows Corporation Infusion apparatus and method
US4265241A (en) * 1979-02-28 1981-05-05 Andros Incorporated Implantable infusion device
US4373527B1 (en) * 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4312347A (en) * 1980-02-25 1982-01-26 Iowa State University Research Foundation, Inc. Positive pressure drug releasing device
US4360007A (en) * 1980-08-05 1982-11-23 Yeda Research And Development Co., Ltd. Remote controlled magnetic actuator particularly for an implantable device like a valve
US4346709A (en) 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
US4416659A (en) 1981-11-09 1983-11-22 Eli Lilly And Company Sustained release capsule for ruminants
US4439182A (en) 1982-03-15 1984-03-27 Huang Shing S J Valvular infusion device
NZ200564A (en) 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4443218A (en) * 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
US4457752A (en) * 1982-09-13 1984-07-03 Csaba Vadasz Surgically implantable pump
US4623334A (en) 1983-03-07 1986-11-18 Vanderbilt University Intravenous drug infusion apparatus
CA1237600A (en) * 1983-05-31 1988-06-07 Tatsuhei Kondo Non-contact controlled micropump
US4543955A (en) * 1983-08-01 1985-10-01 Cordis Corporation System for controlling body implantable action device
IL69431A (en) 1983-08-04 1987-12-31 Omikron Scient Ltd Liquid delivery system particularly useful as an implantable micro-pump for delivering insulin or other drugs
NL8302860A (en) * 1983-08-15 1985-03-01 Stichting Ct Voor Micro Elektr PIEZO ELECTRIC MICRO PUMP.
US4540403A (en) 1984-07-02 1985-09-10 Alza Corporation Parenteral dispensing system with programmable drug administration
AU588828B2 (en) 1984-09-14 1989-09-28 Commonwealth Scientific And Industrial Research Organisation Controlled release capsule
CA1254091A (en) 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
US4677967A (en) * 1984-11-01 1987-07-07 New Mexico State University Foundation Intravaginal anchor
GB8428222D0 (en) * 1984-11-08 1984-12-19 Bentall R H C Quantifying interaction of induced currents
US4668219A (en) 1984-11-16 1987-05-26 Israel Michael B Exponential mixing and delivery system
US4589867A (en) 1984-11-16 1986-05-20 Israel Michael B Exponential mixing and delivery system
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4675006A (en) * 1986-01-06 1987-06-23 Regents Of The University Of Minnesota Needle support system
US4714462A (en) 1986-02-03 1987-12-22 Intermedics Infusaid, Inc. Positive pressure programmable infusion pump
US5019372A (en) 1986-06-27 1991-05-28 The Children's Medical Center Corporation Magnetically modulated polymeric drug release system
AU591297B2 (en) * 1986-07-15 1989-11-30 Pitman-Moore Australia Limited Intra-ruminal depot
US4758463A (en) 1986-12-29 1988-07-19 Viskase Corporation Cook-in shrink film
GB8701731D0 (en) * 1987-01-27 1987-03-04 Patcentre Benelux Nv Sa Pumps
EP0287920B1 (en) 1987-04-22 1991-05-15 Siemens Aktiengesellschaft Piston pump for a device for dosing medicaments
US4838887A (en) 1987-12-15 1989-06-13 Shiley Infusaid Inc. Programmable valve pump
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
US5011472A (en) * 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US4978337A (en) 1988-09-08 1990-12-18 Alza Corporation Formulation chamber with exterior electrotransport delivery device
US4969872A (en) 1989-03-08 1990-11-13 Alza Corporation Intravenous system for delivering a beneficial agent with delivery rate control via permeable surface area variance
US5041107A (en) * 1989-10-06 1991-08-20 Cardiac Pacemakers, Inc. Electrically controllable, non-occluding, body implantable drug delivery system
US5059175A (en) * 1990-10-09 1991-10-22 University Of Utah Research Foundation Implantable drug delivery system with piston actuation
US5328460A (en) * 1991-06-21 1994-07-12 Pacesetter Infusion, Ltd. Implantable medication infusion pump including self-contained acoustic fault detection apparatus
US5330505A (en) * 1992-05-08 1994-07-19 Leonard Bloom System for and method of treating a malfunctioning heart
US5318557A (en) 1992-07-13 1994-06-07 Elan Medical Technologies Limited Medication administering device
NL9400410A (en) * 1994-03-16 1995-11-01 M D Ph D Willem Arthur Adriaan Intrauterine contraceptive.
US5556421A (en) * 1995-02-22 1996-09-17 Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
AU716398B2 (en) * 1995-03-23 2000-02-24 Advanced Animal Technology Limited Substance delivery device including a retention apparatus
IL118689A (en) 1996-06-20 2000-10-31 Gadot Amir Intravenous infusion apparatus
US6112116A (en) * 1999-02-22 2000-08-29 Cathco, Inc. Implantable responsive system for sensing and treating acute myocardial infarction

Also Published As

Publication number Publication date
EP0820258B1 (en) 2002-10-09
US6500168B1 (en) 2002-12-31
US20020165487A1 (en) 2002-11-07
DE69624227T2 (en) 2003-06-12
EP0990425B1 (en) 2003-01-15
AU5127496A (en) 1996-10-08
EP0988838A3 (en) 2000-05-24
US6436069B1 (en) 2002-08-20
EP0820258A4 (en) 1998-09-23
US20020045883A1 (en) 2002-04-18
EP0988838A2 (en) 2000-03-29
US6780168B2 (en) 2004-08-24
WO1996029025A1 (en) 1996-09-26
DE69624227D1 (en) 2002-11-14
DE69625831T2 (en) 2003-11-20
DE69628344T2 (en) 2004-04-01
AU716398B2 (en) 2000-02-24
EP0988838B1 (en) 2003-05-21
EP0990425A3 (en) 2000-05-24
DE820258T1 (en) 1998-04-30
DE69625831D1 (en) 2003-02-20
EP0990425A2 (en) 2000-04-05
US6375649B1 (en) 2002-04-23
DE69628344D1 (en) 2003-06-26
EP0820258A1 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
CA2216256A1 (en) Substance delivery device
US6962579B2 (en) Substance delivery device
US20050245902A1 (en) Substance delivery device
US4312347A (en) Positive pressure drug releasing device
US6352524B1 (en) Active delivery device with reduced passive delivery
AU2553899A (en) Drug delivery system
EP1021137B1 (en) Drug delivery system
AU745389B2 (en) Substance delivery device including a delivery apparatus
AU745984B2 (en) Substance delivery device including a control means
NZ500444A (en) Implantable pump for delivering medication to animals, pump controlled by microprocessor
AU755686B2 (en) Active delivery device with reduced passive delivery
NZ521404A (en) Method for maintaining progesterone plasma levels
US20070051325A1 (en) Veterinary apparatus and method of use
NZ314175A (en) Intra-vaginal delivery device including a bladder of variable volume and gas generating means
NZ506120A (en) Drug delivery system with a central aperture able to slide over a supporting structure and with fingers extending from the support structure which dispense the drug
ITRM20140148U1 (en) DEVICE FOR THE CONTROL OF THE FLOW OF A FLUID INSIDE A BODY EQUIPMENT.
NZ526881A (en) Veterinary apparatus and method of use

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued